Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.
暂无分享,去创建一个
Geoffrey Hom | Ann-Christine Syvänen | Barmak Modrek | Roman Kosoy | Iva Gunnarsson | Timothy W Behrens | Peter K Gregersen | Annette Lee | P. Gregersen | D. Ballinger | M. Petri | A. Syvänen | B. Modrek | L. Criswell | M. Seldin | T. Behrens | L. Rönnblom | R. Graham | W. Ortmann | S. Rantapää-Dahlqvist | P. Pant | A. Bengtsson | F. Demirci | R. Ferreira | M. Kamboh | I. Gunnarsson | C. Tian | R. Kosoy | S. Chung | S. Manzi | G. Hom | K. Taylor | Michael F Seldin | Annette T Lee | Michelle Petri | Dennis G Ballinger | Lindsey A Criswell | Robert R Graham | Lars Rönnblom | Sharon A Chung | Kimberly E Taylor | Ward Ortmann | Ricardo C Ferreira | Anders A Bengtsson | Solbritt Rantapää-Dahlqvist | Susan Manzi | A. Kao | M Ilyas Kamboh | P V Krishna Pant | F Yesim Demirci | S. Garnier | Sophie Garnier | Amy H Kao | Chao Tian | Sharon A. Chung | Chaoyong Tian | Geoffrey Hom | Annette Lee | Ricardo C. Ferreira | P.V. Krishna Pant | Dennis G. Ballinger | Amy H. Kao | Anders A. Bengtsson | Michael F. Seldin | Sharon A. Chung | Ricardo C. Ferreira | P.V. Krishna Pant | Dennis G. Ballinger | A. Bengtsson | Peter K Gregersen | P. Gregersen | S. Chung | Annette T. Lee | Sharon A. Chung | Peter K. Gregersen | M. I. Kamboh | Sharon A Chung | F. Y. Demirci
[1] L. Liang,et al. A genome-wide association study of global gene expression , 2007, Nature Genetics.
[2] Jennifer Louten,et al. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells , 2007, The Journal of experimental medicine.
[3] D. Koller,et al. Population genomics of human gene expression , 2007, Nature Genetics.
[4] Wentian Li,et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.
[5] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[6] P. Gregersen,et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE , 2007, European Journal of Human Genetics.
[7] Yufang Shi,et al. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation , 2007, The Journal of experimental medicine.
[8] F. Demirci,et al. Association of a Common Interferon Regulatory Factor 5 (IRF5) Variant with Increased Risk of Systemic Lupus Erythematosus (SLE) , 2007, Annals of human genetics.
[9] Geoffrey Hom,et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus , 2007, Proceedings of the National Academy of Sciences.
[10] Wentian Li,et al. Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.
[11] Pardis C Sabeti,et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.
[12] V. Pascual,et al. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.
[13] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[14] C. Mohan,et al. Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108 , 2006, Science.
[15] Marta E Alarcón-Riquelme,et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.
[16] Stephen B. Johnson,et al. The New York cancer project: Rationale, organization, design, and baseline characteristics , 2004, Journal of Urban Health.
[17] Weihua Chang,et al. Whole-genome genotyping. , 2006, Methods in enzymology.
[18] Joshua T. Burdick,et al. Mapping determinants of human gene expression by regional and genome-wide association , 2005, Nature.
[19] Alexander R. Abbas,et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data , 2005, Genes and Immunity.
[20] Annette Lee,et al. Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .
[21] C. Ballantyne,et al. Manifestations of Inflammatory Arthritis Are Critically Dependent on LFA-11 , 2005, The Journal of Immunology.
[22] J. Kere,et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.
[23] M. Daly,et al. Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.
[24] J. Harley,et al. Genetics of human systemic lupus erythematosus: the emerging picture. , 2004, Current opinion in immunology.
[25] P. Gregersen,et al. The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.
[26] Jessica L. Dunne,et al. Mac-1, but Not LFA-1, Uses Intercellular Adhesion Molecule-1 to Mediate Slow Leukocyte Rolling in TNF-α-Induced Inflammation 1 , 2003, The Journal of Immunology.
[27] D. Ledbetter,et al. Complex low-copy repeats associated with a common polymorphic inversion at human chromosome 8p23. , 2003, Genomics.
[28] H. Kaplan,et al. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells , 2003, Nature Medicine.
[29] James T. Elder,et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. , 2002, American journal of human genetics.
[30] L. Rönnblom,et al. A Pivotal Role for the Natural Interferon α–producing Cells (Plasmacytoid Dendritic Cells) in the Pathogenesis of Lupus , 2001, The Journal of experimental medicine.
[31] T. Behrens,et al. Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.
[32] T. M. Hsu,et al. Universal SNP genotyping assay with fluorescence polarization detection. , 2001, BioTechniques.
[33] J. Weber,et al. Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. , 2001, American journal of human genetics.
[34] L. Criswell,et al. The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. , 2001, Arthritis and rheumatism.
[35] B Devlin,et al. Genomic control for association studies: a semiparametric test to detect excess-haplotype sharing. , 2000, Biostatistics.
[36] D. Nemazee,et al. Revising B Cell Receptors , 2000, The Journal of experimental medicine.
[37] K. Rajewsky,et al. The B-Cell-Specific src-Family Kinase Blk Is Dispensable for B-Cell Development and Activation , 2000, Molecular and Cellular Biology.
[38] S. Katiyar,et al. Activated Complement Component 3 (C3) Is Required for Ultraviolet Induction of Immunosuppression and Antigenic Tolerance , 1998, The Journal of experimental medicine.
[39] C. Goodnow,et al. B cell antigen receptor signalling in the balance of tolerance and immunity. , 1998, Novartis Foundation symposium.
[40] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[41] A. Beaudet,et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. , 1997, The Journal of clinical investigation.
[42] F. Alt,et al. Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.
[43] R. Hardy,et al. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. , 1995, Journal of immunology.
[44] Ornella Parolini,et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.
[45] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[46] K. Zeller,et al. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. , 1992, The Journal of biological chemistry.
[47] M. Hochberg,et al. Systemic lupus erythematosus. , 1990, Rheumatic diseases clinics of North America.
[48] R. Winchester,et al. Surface expression of gp165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus , 1988 .
[49] F. Arnett,et al. Histocompatibility antigens in systemic lupus erythematosus. , 1976, Arthritis and rheumatism.
[50] Stanley L. Lee,et al. The epidemiology of systemic lupus erythematosus. , 1973, Seminars in arthritis and rheumatism.